| Year |
Citation |
Score |
| 2022 |
Lee SH, Hao Y, Gui T, Dotti G, Savoldo B, Zou F, Kafri T. Inadvertent Transfer of Murine VL30 Retrotransposons to CAR-T Cells. Advances in Cell and Gene Therapy. 2022. PMID 36081760 DOI: 10.1155/2022/6435077 |
0.362 |
|
| 2019 |
Hunt R, Hettiarachchi G, Katneni U, Hernandez N, Holcomb D, Kames J, Alnifaidy R, Lin B, Hamasaki-Katagiri N, Wesley A, Kafri T, Morris C, Bouché L, Panico M, Schiller T, et al. A Single Synonymous Variant (c.354G>A [p.P118P]) in Confers Enhanced Specific Activity. International Journal of Molecular Sciences. 20. PMID 31731663 DOI: 10.3390/Ijms20225734 |
0.331 |
|
| 2019 |
Song L, Song Z, Fry NJ, Conatser L, Llanga TA, Mei H, Kafri T, Hirsch M. Gene Delivery to Human Limbal Stem Cells using Viral Vectors. Human Gene Therapy. PMID 31392914 DOI: 10.1089/Hum.2019.071 |
0.431 |
|
| 2018 |
Hu P, Bi Y, Ma H, Suwanmanee T, Zeithaml B, Fry NJ, Kohn DB, Kafri T. Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization. Gene Therapy. PMID 30190607 DOI: 10.1038/S41434-018-0039-2 |
0.543 |
|
| 2018 |
Simmons AB, Bretz CA, Wang H, Kunz E, Hajj K, Kennedy C, Yang Z, Suwanmanee T, Kafri T, Hartnett ME. Gene therapy knockdown of VEGFR2 in retinal endothelial cells to treat retinopathy. Angiogenesis. PMID 29730824 DOI: 10.1007/S10456-018-9618-5 |
0.3 |
|
| 2017 |
Suwanmanee T, Ferris MT, Hu P, Gui T, Montgomery SA, Pardo-Manuel de Villena F, Kafri T. Toward Personalized Gene Therapy: Characterizing the Host Genetic Control of Lentiviral-Vector-Mediated Hepatic Gene Delivery. Molecular Therapy. Methods & Clinical Development. 5: 83-92. PMID 28480308 DOI: 10.1016/J.Omtm.2017.03.009 |
0.423 |
|
| 2016 |
Hu P, Li Y, Nikolaishvili-Feinberg N, Scesa G, Bi Y, Pan D, Moore D, Bongarzone ER, Sands MS, Miller R, Kafri T. Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospects. Journal of Neuroscience Research. 94: 1152-68. PMID 27638600 DOI: 10.1002/Jnr.23847 |
0.403 |
|
| 2015 |
Hu P, Li Y, Sands MS, McCown T, Kafri T. Generation of a stable packaging cell line producing high-titer PPT-deleted integration-deficient lentiviral vectors. Molecular Therapy. Methods & Clinical Development. 2: 15025. PMID 26229972 DOI: 10.1038/Mtm.2015.25 |
0.452 |
|
| 2015 |
Monahan PE, Sun J, Gui T, Hu G, Hannah WB, Wichlan DG, Wu Z, Grieger JC, Li C, Suwanmanee T, Stafford DW, Booth CJ, Samulski JJ, Kafri T, McPhee SW, et al. Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trial. Human Gene Therapy. 26: 69-81. PMID 25419787 DOI: 10.1089/Hum.2014.106 |
0.385 |
|
| 2015 |
Shen S, Berry GE, Castellanos Rivera RM, Cheung RY, Troupes AN, Brown SM, Kafri T, Asokan A. Functional analysis of the putative integrin recognition motif on adeno-associated virus 9. The Journal of Biological Chemistry. 290: 1496-504. PMID 25404742 DOI: 10.1074/Jbc.M114.608281 |
0.365 |
|
| 2014 |
Yi G, Choi JG, Bharaj P, Abraham S, Dang Y, Kafri T, Alozie O, Manjunath MN, Shankar P. CCR5 Gene Editing of Resting CD4(+) T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice. Molecular Therapy. Nucleic Acids. 3: e198. PMID 28183539 DOI: 10.1038/mtna.2014.52 |
0.316 |
|
| 2014 |
Yi G, Choi JG, Bharaj P, Abraham S, Dang Y, Kafri T, Alozie O, Manjunath MN, Shankar P. CCR5 Gene Editing of Resting CD4(+) T Cells by Transient ZFN Expression From HIV Envelope Pseudotyped Nonintegrating Lentivirus Confers HIV-1 Resistance in Humanized Mice. Molecular Therapy. Nucleic Acids. 3: e198. PMID 25268698 DOI: 10.1038/Mtna.2014.52 |
0.421 |
|
| 2014 |
Suwanmanee T, Hu G, Gui T, Bartholomae CC, Kutschera I, von Kalle C, Schmidt M, Monahan PE, Kafri T. Integration-deficient lentiviral vectors expressing codon-optimized R338L human FIX restore normal hemostasis in Hemophilia B mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 567-74. PMID 23941813 DOI: 10.1038/Mt.2013.188 |
0.424 |
|
| 2013 |
Wang H, Smith GW, Yang Z, Jiang Y, McCloskey M, Greenberg K, Geisen P, Culp WD, Flannery J, Kafri T, Hammond S, Hartnett ME. Short hairpin RNA-mediated knockdown of VEGFA in Müller cells reduces intravitreal neovascularization in a rat model of retinopathy of prematurity. The American Journal of Pathology. 183: 964-74. PMID 23972394 DOI: 10.1016/J.Ajpath.2013.05.011 |
0.305 |
|
| 2013 |
Li C, He Y, Nicolson S, Hirsch M, Weinberg MS, Zhang P, Kafri T, Samulski RJ. Adeno-associated virus capsid antigen presentation is dependent on endosomal escape. The Journal of Clinical Investigation. 123: 1390-401. PMID 23454772 DOI: 10.1172/Jci66611 |
0.35 |
|
| 2011 |
Cockrell AS, van Praag H, Santistevan N, Ma H, Kafri T. The HIV-1 Rev/RRE system is required for HIV-1 5' UTR cis elements to augment encapsidation of heterologous RNA into HIV-1 viral particles. Retrovirology. 8: 51. PMID 21702950 DOI: 10.1186/1742-4690-8-51 |
0.652 |
|
| 2011 |
Johnson JS, Gentzsch M, Zhang L, Ribeiro CM, Kantor B, Kafri T, Pickles RJ, Samulski RJ. AAV exploits subcellular stress associated with inflammation, endoplasmic reticulum expansion, and misfolded proteins in models of cystic fibrosis. Plos Pathogens. 7: e1002053. PMID 21625534 DOI: 10.1371/Journal.Ppat.1002053 |
0.331 |
|
| 2011 |
Kantor B, Bayer M, Ma H, Samulski J, Li C, McCown T, Kafri T. Notable reduction in illegitimate integration mediated by a PPT-deleted, nonintegrating lentiviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 19: 547-56. PMID 21157436 DOI: 10.1038/Mt.2010.277 |
0.677 |
|
| 2010 |
Monahan PE, Lothrop CD, Sun J, Hirsch ML, Kafri T, Kantor B, Sarkar R, Tillson DM, Elia JR, Samulski RJ. Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application. Molecular Therapy : the Journal of the American Society of Gene Therapy. 18: 1907-16. PMID 20700109 DOI: 10.1038/Mt.2010.170 |
0.477 |
|
| 2009 |
Kantor B, Ma H, Webster-Cyriaque J, Monahan PE, Kafri T. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proceedings of the National Academy of Sciences of the United States of America. 106: 18786-91. PMID 19843699 DOI: 10.1073/Pnas.0905859106 |
0.424 |
|
| 2008 |
Bayer M, Kantor B, Cockrell A, Ma H, Zeithaml B, Li X, McCown T, Kafri T. A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 1968-76. PMID 18797449 DOI: 10.1038/Mt.2008.199 |
0.738 |
|
| 2007 |
Cockrell AS, Kafri T. Gene delivery by lentivirus vectors. Molecular Biotechnology. 36: 184-204. PMID 17873406 DOI: 10.1007/S12033-007-0010-8 |
0.702 |
|
| 2007 |
Li C, Hirsch M, Asokan A, Zeithaml B, Ma H, Kafri T, Samulski RJ. Adeno-associated virus type 2 (AAV2) capsid-specific cytotoxic T lymphocytes eliminate only vector-transduced cells coexpressing the AAV2 capsid in vivo. Journal of Virology. 81: 7540-7. PMID 17475652 DOI: 10.1128/Jvi.00529-07 |
0.475 |
|
| 2006 |
Bahi A, Boyer F, Kafri T, Dreyer JL. Silencing urokinase in the ventral tegmental area in vivo induces changes in cocaine-induced hyperlocomotion. Journal of Neurochemistry. 98: 1619-31. PMID 16923171 DOI: 10.1111/J.1471-4159.2006.04013.X |
0.364 |
|
| 2006 |
Cockrell AS, Ma H, Fu K, McCown TJ, Kafri T. A trans-lentiviral packaging cell line for high-titer conditional self-inactivating HIV-1 vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 276-84. PMID 16516556 DOI: 10.1016/J.Ymthe.2005.12.015 |
0.691 |
|
| 2006 |
Zeithaml BJ, Titus M, Haack K, Cockrell A, Ponguta A, Wilson E, Mohler J, Kafri T. 946. Effect of Androgen Receptor Suppression Using Dominant Negative Inhibition on Castration-Resistant Prostate Cancer Molecular Therapy. 13: S365. DOI: 10.1016/J.Ymthe.2006.08.1037 |
0.616 |
|
| 2005 |
Kafri T. Air-conditioning for regulated transgene expression Gene Therapy. 12: 383-385. PMID 19202636 DOI: 10.1038/Sj.Gt.3302451 |
0.312 |
|
| 2005 |
Martin DR, Haack K, Niemeyer GP, Cox NR, Kafri T, Baker HJ. 962. Treatment of Feline GM1 Gangliosidosis with Mesenchymal Stem Cells and Lentiviral Gene Therapy Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.505 |
0.324 |
|
| 2005 |
Ma H, Cockrell A, Bash R, VanDyke T, Kafri T. 822. A Rev/RRE Dependent Packaging System for MLV Based Vectors Raises Biosafety Concerns Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.365 |
0.674 |
|
| 2005 |
Cockrell AS, Ma H, McCown T, Kluckman KD, Thresher RJ, Kafri T. 478. A HIV-1 Based Cross-Packaging System for FIV Vectors Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.018 |
0.522 |
|
| 2005 |
Suwanmanee T, Choi VW, Samulski RJ, Kafri T, Kole R. 343. Repair of Thalassemic |[beta]|-Globin pre-mRNA by Antisense AAV and Lentiviral Vectors in Cell Culture Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.06.346 |
0.407 |
|
| 2004 |
Haack K, Cockrell AS, Ma H, Israeli D, Ho SN, McCown TJ, Kafri T. Transactivator and structurally optimized inducible lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 585-96. PMID 15336658 DOI: 10.1016/J.Ymthe.2004.06.109 |
0.729 |
|
| 2004 |
Logan AC, Haas DL, Kafri T, Kohn DB. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration. Journal of Virology. 78: 8421-36. PMID 15280451 DOI: 10.1128/Jvi.78.16.8421-8436.2004 |
0.435 |
|
| 2004 |
Ma H, Kafri T. A single-LTR HIV-1 vector optimized for functional genomics applications. Molecular Therapy : the Journal of the American Society of Gene Therapy. 10: 139-49. PMID 15272477 DOI: 10.1016/J.Ymthe.2004.04.012 |
0.481 |
|
| 2004 |
Bahi A, Boyer F, Kafri T, Dreyer JL. CD81-induced behavioural changes during chronic cocaine administration: in vivo gene delivery with regulatable lentivirus. The European Journal of Neuroscience. 19: 1621-33. PMID 15066158 DOI: 10.1111/J.1460-9568.2004.03260.X |
0.315 |
|
| 2004 |
Kafri T. Gene delivery by lentivirus vectors an overview. Methods in Molecular Biology (Clifton, N.J.). 246: 367-90. PMID 14970605 DOI: 10.1385/1-59259-650-9:367 |
0.467 |
|
| 2004 |
Ma H, Kafri T. 75. The Optimization of a Single-LTR HIV-1 Vectors for Functional Genomic Applications Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.010 |
0.462 |
|
| 2004 |
Cockrell AS, Fu K, Ma H, McCown T, Kafri T. 69. Closing-in on the titer gap between transient transfection and packaging cell lines Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.004 |
0.459 |
|
| 2003 |
Cockrell AS, Kafri T. HIV-1 vectors: fulfillment of expectations, further advancements, and still a way to go. Current Hiv Research. 1: 419-39. PMID 15049428 DOI: 10.2174/1570162033485104 |
0.706 |
|
| 2002 |
Pan D, Gunther R, Duan W, Wendell S, Kaemmerer W, Kafri T, Verma IM, Whitley CB. Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow. Molecular Therapy : the Journal of the American Society of Gene Therapy. 6: 19-29. PMID 12095299 DOI: 10.1006/Mthe.2002.0630 |
0.42 |
|
| 2001 |
Kafri T. Lentivirus vectors: Difficulties and hopes before clinical trials Current Opinion in Molecular Therapeutics. 3: 316-326. PMID 11525555 |
0.394 |
|
| 2001 |
Xu K, Ma H, McCown TJ, Verma IM, Kafri T. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors. Molecular Therapy : the Journal of the American Society of Gene Therapy. 3: 97-104. PMID 11162316 DOI: 10.1006/Mthe.2000.0238 |
0.51 |
|
| 2000 |
Kafri T, Van Praag H, Gage FH, Verma IM. Lentiviral vectors: Regulated gene expression Molecular Therapy. 1: 516-521. PMID 10933976 DOI: 10.1006/Mthe.2000.0083 |
0.383 |
|
| 1999 |
Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM. A packaging cell line for lentivirus vectors. Journal of Virology. 73: 576-84. PMID 9847362 DOI: 10.1128/Jvi.73.1.576-584.1999 |
0.324 |
|
| 1999 |
Kafri T, van Praag H, Ouyang L, Gage FH, Verma IM. A Packaging Cell Line for Lentivirus Vectors Journal of Virology. 73: 576-584. DOI: 10.1128/jvi.73.1.576-584.1999 |
0.322 |
|
| 1998 |
Kafri T, Morgan D, Krahl T, Sarvetnick N, Sherman L, Verma I. Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy. Proceedings of the National Academy of Sciences of the United States of America. 95: 11377-82. PMID 9736744 DOI: 10.1073/Pnas.95.19.11377 |
0.323 |
|
| 1997 |
Kafri T, Blömer U, Peterson DA, Gage FH, Verma IM. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nature Genetics. 17: 314-7. PMID 9354796 DOI: 10.1038/Ng1197-314 |
0.398 |
|
| 1997 |
Blömer U, Naldini L, Kafri T, Trono D, Verma IM, Gage FH. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. Journal of Virology. 71: 6641-9. PMID 9261386 DOI: 10.1128/Jvi.71.9.6641-6649.1997 |
0.366 |
|
| Show low-probability matches. |